Core Scientific, Inc./tx (CORZR) EBIT (2020 - 2026)

Core Scientific (CORZR) has 7 years of EBIT data on file, last reported at -$310.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 559.94% year-over-year to -$310.4 million; the trailing twelve-month figure through Mar 2026 stood at -$509.0 million (down 108.31% YoY), and the FY2025 full-year result was -$245.6 million, down 72.87% from the prior year.
• EBIT declined to -$310.4 million in Q1 2026, from -$117.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $55.2 million in Q1 2024 to a low of -$1.0 billion in Q2 2022.
• A 5-year average of -$164.6 million and a median of -$47.0 million in 2025 frame the typical range for EBIT.
• Across the five-year window, EBIT plunged 8489.92% in 2022 and surged 626.48% in 2024, its largest moves.
• Tracing CORZR's EBIT over 5 years: stood at -$636.1 million in 2022, then soared by 100.62% to $3.9 million in 2023, then slumped by 1762.2% to -$65.4 million in 2024, then plunged by 79.65% to -$117.5 million in 2025, then slumped by 164.25% to -$310.4 million in 2026.
• Business Quant data shows CORZR's EBIT at -$310.4 million in Q1 2026, -$117.5 million in Q4 2025, and -$54.8 million in Q3 2025.